On June 12, Cerebras Systems fell 5.32% in regular trading, trading at 215.17 USD/share, with turnover of $137 million.

On the news front, multiple top-tier investment banks recently initiated coverage on the stock with bullish ratings — including Citi with a Buy rating and $340 target, UBS at Buy with $300 target, Craig-Hallum at Buy with $325 target, Barclays at Outperform with $280 target, and Morgan Stanley at Overweight with $250 target. However, as this collective catalyst has been progressively digested, profit-taking pressure continues to mount. The stock had previously rebounded to approximately $241 on the coverage wave before reversing course.

Additionally, the S&P index inclusion benefit — confirmed effective May 25 under the large IPO fast-track rule — has been fully priced in, and the post-inclusion adjustment trend remains intact. The company's post-IPO price-to-sales ratio significantly exceeds the industry average, with elevated valuation facing sustained headwinds in the current interest rate environment. Semiconductor sector weakness further compounded downside pressure, with Micron Technology down 2.57% and Marvell Technology down 1.57%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)